Zobrazeno 1 - 10
of 23
pro vyhledávání: '"I. Schillevoort"'
Publikováno v:
Pharmacoepidemiology and Drug Safety. 14:25-30
Purpose The aim of the study was to investigate whether the most recent introduced atypical antipsychotics olanzapine and risperidone were preferentially prescribed to patients susceptible to develop extrapyramidal side effects (EPS) and those not re
Autor:
Linda S. W. Steijns, I. Schillevoort, Anthonius de Boer, Raymund A.C. Roos, Paul A. F. Jansen, Jan van der Weide, Hubert G. M. Leufkens
Publikováno v:
Pharmacogenetics. 12:235-240
To study the association between polymorphism of the cytochrome P450 2D6 gene (CYP2D6) and the risk of antipsychotic-induced extrapyramidal syndromes, as measured by the use of antiparkinsonian medication. Data for this case-control study were obtain
Autor:
Paul A. F. Jansen, I. Schillevoort, Raymund A.C. Roos, A. de Boer, Hubert G. M. Leufkens, Rmc Herings
Publikováno v:
European Journal of Clinical Pharmacology. 57:327-331
Aim: To compare the risk of extrapyramidal syndromes (EPS) between patients using risperidone and those using low-potency conventional antipsychotic drugs (APDs) in outpatient clinical practice, as measured by the use of anticholinergic medication. W
Autor:
Anthonius de Boer, Raymund A.C. Roos, Ron M. C. Herings, I. Schillevoort, Hubert G. M. Leufkens, Paul A. F. Jansen
Publikováno v:
Schillevoort, I, De Boer, A, Herings, R M C, Roos, R A C, Jansen, P A F & Leufkens, H G M 2001, ' Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine ', Annals of Pharmacotherapy, vol. 35, no. 12, pp. 1517-1522 . https://doi.org/10.1345/aph.1A068
Annals of Pharmacotherapy, 35(12), 1517-1522. Harvey Whitney Books Company
Annals of Pharmacotherapy, 35(12), 1517-1522. Harvey Whitney Books Company
OBJECTIVE: To compare the risk of extrapyramidal syndrome (EPS) between risperidone, olanzapine, and haloperidol, taking into account patients' past antipsychotic drug use and past EPS. METHODS: Data were obtained from the PHARMO-database, containing
Autor:
I. Schillevoort, Raymund A.C. Roos, E P van Puijenbroek, A. de Boer, Hubert G. M. Leufkens, Paul A. F. Jansen
Publikováno v:
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 17(2), 75-79. LIPPINCOTT WILLIAMS & WILKINS
The aim of this study was to assess whether use of selective serotonin reuptake inhibitors (SSRIs) is associated with extrapyramidal syndromes (EPS). We analysed the spontaneous reports of adverse drug reactions (ADRs) collected by The Netherlands Ph
Publikováno v:
European journal of clinical pharmacology. 57(4)
To compare the risk of extrapyramidal syndromes (EPS) between patients using risperidone and those using low-potency conventional antipsychotic drugs (APDs) in outpatient clinical practice, as measured by the use of anticholinergic medication. We tri
Autor:
R. M. C. Herings, Raymund A.C. Roos, I. Schillevoort, Hubert G. M. Leufkens, Paul A. F. Jansen
Publikováno v:
European Neuropsychopharmacology. 10:314
Publikováno v:
Pharmacy World & Science; Aug2005, Vol. 27 Issue 4, p285-289, 5p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.